CFGS
SRNE

Concourse Financial Group Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Concourse Financial Group Securities’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25
Closed -$8 – 2457
2023
Q2 		$8 Hold
25
– – ﹤0.01% 2325
2023
Q1 		$9 Buy
+25
New +$22 ﹤0.01% 2354
2022
Q1 		– Sell
-2,050
Closed -$6.39K – 2499
2021
Q4 		$10K Hold
2,050
– – ﹤0.01% 1875
2021
Q3 		$16K Hold
2,050
– – ﹤0.01% 1738
2021
Q2 		$20K Hold
2,050
– – ﹤0.01% 1658
2021
Q1 		$17K Hold
2,050
– – ﹤0.01% 1620
2020
Q4 		$14K Sell
2,050
-300
-13% -$2.41K ﹤0.01% 1592
2020
Q3 		$26K Buy
2,350
+300
+15% +$2.75K ﹤0.01% 1287
2020
Q2 		$13K Buy
+2,050
New +$7.85K ﹤0.01% 1435

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

Concourse Financial Group Securities's SRNE Position: Q3 2023 in Review

Concourse Financial Group Securities sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2023, closing a stake of 25 shares — an estimated $8 sold.

Concourse Financial Group Securities first reported a position in SRNE in Q2 2020 and held it in 9 quarters. The position peaked at $26K in Q3 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q3 2023.

  • Concourse Financial Group Securities reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2023 after selling out during the quarter.
  • Concourse Financial Group Securities sold 25 Sorrento Therapeutics, Inc. shares in Q3 2023, an estimated $8.
  • Concourse Financial Group Securities first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 9 quarters.
  • Concourse Financial Group Securities's Sorrento Therapeutics, Inc. position peaked at $26K in Q3 2020.
  • 9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2023.

Based on Concourse Financial Group Securities's 13F filing for Q3 2023, filed 25 Oct 2023.